219 related articles for article (PubMed ID: 16515589)
1. CAG repeat length in exon 1 of the androgen receptor gene is related to age of diagnosis but not germ line BRCA1 mutation status in ovarian cancer.
Kim SC; Ju W; Mahavni V; Geisler JP; Buller RE
Int J Gynecol Cancer; 2006; 16 Suppl 1():190-4. PubMed ID: 16515589
[TBL] [Abstract][Full Text] [Related]
2. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat.
Rebbeck TR; Kantoff PW; Krithivas K; Neuhausen S; Blackwood MA; Godwin AK; Daly MB; Narod SA; Garber JE; Lynch HT; Weber BL; Brown M
Am J Hum Genet; 1999 May; 64(5):1371-7. PubMed ID: 10205268
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype.
Dagan E; Friedman E; Paperna T; Carmi N; Gershoni-Baruch R
Eur J Hum Genet; 2002 Nov; 10(11):724-8. PubMed ID: 12404104
[TBL] [Abstract][Full Text] [Related]
4. Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers.
Li AJ; McAllister P; Karlan BY
Gynecol Oncol; 2010 Jan; 116(1):105-8. PubMed ID: 19818997
[TBL] [Abstract][Full Text] [Related]
5. The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Spurdle AB; Antoniou AC; Duffy DL; Pandeya N; Kelemen L; Chen X; Peock S; Cook MR; Smith PL; Purdie DM; Newman B; Dite GS; Apicella C; Southey MC; Giles GG; Hopper JL; Chenevix-Trench G; Easton DF;
Breast Cancer Res; 2005; 7(2):R176-83. PubMed ID: 15743497
[TBL] [Abstract][Full Text] [Related]
6. The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series.
Levine DA; Boyd J
Cancer Res; 2001 Feb; 61(3):908-11. PubMed ID: 11221880
[TBL] [Abstract][Full Text] [Related]
7. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers.
Kadouri L; Easton DF; Edwards S; Hubert A; Kote-Jarai Z; Glaser B; Durocher F; Abeliovich D; Peretz T; Eeles RA
Br J Cancer; 2001 Jul; 85(1):36-40. PubMed ID: 11437399
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer.
Menin C; Banna GL; De Salvo G; Lazzarotto V; De Nicolo A; Agata S; Montagna M; Sordi G; Nicoletto O; Chieco-Bianchi L; D'Andrea E
Cancer Lett; 2001 Jul; 168(1):31-6. PubMed ID: 11368874
[TBL] [Abstract][Full Text] [Related]
9. Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinoma.
Li AJ; Baldwin RL; Karlan BY
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3667-73. PubMed ID: 14506156
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic CAG repeat length within the androgen receptor gene: identification of a subgroup of patients with increased risk of ovarian cancer.
Santarosa M; Bidoli E; Gallo A; Steffan A; Boiocchi M; Viel A
Oncol Rep; 2002; 9(3):639-44. PubMed ID: 11956643
[TBL] [Abstract][Full Text] [Related]
11. The androgen receptor cytosine-adenine-guanine repeat length contributes to the development of epithelial ovarian cancer.
Meng X; Lu P; Chu Z; Fan Q
Oncotarget; 2016 Jan; 7(2):2105-12. PubMed ID: 26556855
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor gene polymorphism and prostate cancer in Taiwan.
Huang SP; Chou YH; Chang WS; Wu MT; Yu CC; Wu T; Lee YH; Huang JK; Wu WJ; Huang CH
J Formos Med Assoc; 2003 Oct; 102(10):680-6. PubMed ID: 14691592
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer.
Spurdle AB; Webb PM; Chen X; Martin NG; Giles GG; Hopper JL; Chenevix-Trench G
Int J Cancer; 2000 Sep; 87(5):637-43. PubMed ID: 10925355
[TBL] [Abstract][Full Text] [Related]
14. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk.
Bratt O; Borg A; Kristoffersson U; Lundgren R; Zhang QX; Olsson H
Br J Cancer; 1999 Oct; 81(4):672-6. PubMed ID: 10574254
[TBL] [Abstract][Full Text] [Related]
15. The androgen receptor CAG repeat: a modifier of carcinogenesis?
Ferro P; Catalano MG; Dell'Eva R; Fortunati N; Pfeffer U
Mol Cell Endocrinol; 2002 Jul; 193(1-2):109-20. PubMed ID: 12161010
[TBL] [Abstract][Full Text] [Related]
16. Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer.
Schildkraut JM; Murphy SK; Palmieri RT; Iversen E; Moorman PG; Huang Z; Halabi S; Calingaert B; Gusberg A; Marks JR; Berchuck A
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):473-80. PubMed ID: 17372242
[TBL] [Abstract][Full Text] [Related]
17. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
[TBL] [Abstract][Full Text] [Related]
18. Association of androgen receptor CAG repeat polymorphism and risk of epithelial ovarian cancer.
Zhu T; Yuan J; Xie Y; Li H; Wang Y
Gene; 2016 Jan; 575(2 Pt 3):743-6. PubMed ID: 26410037
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.
Wu MH; Chou YC; Yu CP; Yang T; You SL; Chen CJ; Sun CA
Eur J Cancer Prev; 2008 Aug; 17(4):317-22. PubMed ID: 18562955
[TBL] [Abstract][Full Text] [Related]
20. Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer.
Yu H; Bharaj B; Vassilikos EJ; Giai M; Diamandis EP
Breast Cancer Res Treat; 2000 Jan; 59(2):153-61. PubMed ID: 10817350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
